A $7.25 billion settlement class action against Monsanto, filed on February 17, 2026, in the City of St. Louis Circuit Court, aims to resolve thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma. The settlement establishes a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide.
Williams Hart & Boundas, LLP has joined a team of leading plaintiffs' law firms including Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm to achieve this resolution. Over the past several years, juries nationwide have returned significant verdicts linking Roundup to non-Hodgkin lymphoma, while tens of thousands of claims remain pending in state and federal courts.
"After years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Round-Up claims, we are pleased to achieve a resolution that we believe is acceptable based on the current circumstances," said John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP.
According to the settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement is designed to provide a structured and comprehensive resolution framework for individuals diagnosed with non-Hodgkin lymphoma following exposure to the herbicide. Under the proposed settlement, eligible class members will have the right to opt out and pursue their claims individually if they choose.
This settlement represents one of the largest mass tort resolutions in recent history and has significant implications for both plaintiffs and the agricultural chemical industry. The resolution comes as the U.S. Supreme Court prepares to review the validity of Roundup claims, potentially affecting future litigation involving similar products. For more information about legal proceedings, visit https://www.supremecourt.gov.
The case's importance extends beyond immediate compensation, potentially influencing how courts handle future product liability claims involving widely used consumer and agricultural products. The settlement framework could serve as a model for resolving complex mass tort litigation involving multiple jurisdictions and thousands of claimants. As glyphosate remains one of the world's most widely used herbicides, this settlement may prompt increased scrutiny of agricultural chemicals and their long-term health effects.
For individuals affected by non-Hodgkin lymphoma potentially linked to Roundup exposure, this settlement provides a pathway to compensation without requiring lengthy individual litigation. The structured approach aims to streamline the claims process while maintaining individuals' rights to pursue separate legal action if they choose to opt out of the class settlement.
